The CFTC has pushed back hard against the CME Group’s legal challenge to the agency’s recent move to greenlight perpetual futures trading in the U.S.
Background: In May the Commodity Futures Trading Commission opened the door to perpetual (or “perp”) bitcoin contracts by approving the first U.S. product from Kalshi, signaling a willingness to let similar instruments launch domestically. Perpetuals — a dominant form of crypto derivatives overseas — had become a major part of trading in the international market, and the CFTC’s decision was intended to provide a framework for the U.S. market to develop. The step also aligned with President Donald Trump’s pro-crypto policy push, which advocated bringing perps into domestic trading.
The dispute: The CME Group went to court to try to block the CFTC’s approach. In response, the regulator filed a brief on Friday arguing that CME lacks legal standing to sue. The CFTC says CME’s complaint relies on “allegations of increased competition, without any plausible inference of an imminent financial injury,” and therefore does not meet the threshold needed to challenge the agency’s action.
CFTC’s additional point: The brief also notes that trading volume in crypto futures at the CME has actually increased since the CFTC signaled its policy shift — undercutting CME’s claim of imminent harm.
Why it matters: Perps have been a cornerstone of global crypto derivatives markets for years; whether and how they can take root in the U.S. is a consequential regulatory and commercial question. The CFTC has said it will treat these contracts as futures and supervise them on a case-by-case basis, which could open room for new entrants and products — but also invites litigation from incumbents that view the move as competitive pressure.
What’s next: The legal fight will determine who gets a say in how perps evolve in the U.S. — a regulator aiming to enable a domestic market, or legacy derivatives players seeking to limit disruption. The court’s handling of CME’s standing challenge will be an early key decision.
Background: In May the Commodity Futures Trading Commission opened the door to perpetual (or “perp”) bitcoin contracts by approving the first U.S. product from Kalshi, signaling a willingness to let similar instruments launch domestically. Perpetuals — a dominant form of crypto derivatives overseas — had become a major part of trading in the international market, and the CFTC’s decision was intended to provide a framework for the U.S. market to develop. The step also aligned with President Donald Trump’s pro-crypto policy push, which advocated bringing perps into domestic trading.
The dispute: The CME Group went to court to try to block the CFTC’s approach. In response, the regulator filed a brief on Friday arguing that CME lacks legal standing to sue. The CFTC says CME’s complaint relies on “allegations of increased competition, without any plausible inference of an imminent financial injury,” and therefore does not meet the threshold needed to challenge the agency’s action.
CFTC’s additional point: The brief also notes that trading volume in crypto futures at the CME has actually increased since the CFTC signaled its policy shift — undercutting CME’s claim of imminent harm.
Why it matters: Perps have been a cornerstone of global crypto derivatives markets for years; whether and how they can take root in the U.S. is a consequential regulatory and commercial question. The CFTC has said it will treat these contracts as futures and supervise them on a case-by-case basis, which could open room for new entrants and products — but also invites litigation from incumbents that view the move as competitive pressure.
What’s next: The legal fight will determine who gets a say in how perps evolve in the U.S. — a regulator aiming to enable a domestic market, or legacy derivatives players seeking to limit disruption. The court’s handling of CME’s standing challenge will be an early key decision.